img

Global and United States Cattle and Sheep Vaccine Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Cattle and Sheep Vaccine Market Report & Forecast 2024-2034

Cattle and sheep vaccines are vaccines that are specifically designed for use in cattle and sheep to prevent various diseases that can affect these animals. Some of the commonly used cattle and sheep vaccines include those for diseases such as Foot and Mouth Disease (FMD), Brucellosis, Anthrax, and Clostridial diseases like Tetanus and Blackleg. These vaccines are typically administered via injection ingestion and are an important tool for maintaining the health and productivity of cattle and sheep herds.
Market Analysis and InsightsGlobal and United States Cattle and Sheep Vaccine Market
This report focuses on global and United States Cattle and Sheep Vaccine market, also covers the segmentation data of other regions in regional level and county level.
The global Cattle and Sheep Vaccine revenue was US$ 1681 million in 2024 and is forecast to a readjusted size of US$ 2585.6 million by 2034 with a CAGR of 6.5% during the forecast period (2024-2034).
In United States the Cattle and Sheep Vaccine revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Cattle and Sheep Vaccine include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. The global five biggest players hold a share of % in 2024.
Global Cattle and Sheep Vaccine Scope and Market Size
Cattle and Sheep Vaccine market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Cattle and Sheep Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Cattle and Sheep Vaccine market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other

Segment by Application


Cattle
Sheep
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Cattle and Sheep Vaccine definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Cattle and Sheep Vaccine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Cattle and Sheep Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cattle and Sheep Vaccine sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Cattle and Sheep Vaccine Product Introduction
1.2 Global Cattle and Sheep Vaccine Outlook 2018 VS 2024 VS 2034
1.2.1 Global Cattle and Sheep Vaccine Sales in US$ Million for the Year 2018-2034
1.2.2 Global Cattle and Sheep Vaccine Sales in Volume for the Year 2018-2034
1.3 United States Cattle and Sheep Vaccine Outlook 2018 VS 2024 VS 2034
1.3.1 United States Cattle and Sheep Vaccine Sales in US$ Million for the Year 2018-2034
1.3.2 United States Cattle and Sheep Vaccine Sales in Volume for the Year 2018-2034
1.4 Cattle and Sheep Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Cattle and Sheep Vaccine in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Cattle and Sheep Vaccine Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Cattle and Sheep Vaccine Market Dynamics
1.5.1 Cattle and Sheep Vaccine Industry Trends
1.5.2 Cattle and Sheep Vaccine Market Drivers
1.5.3 Cattle and Sheep Vaccine Market Challenges
1.5.4 Cattle and Sheep Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Cattle and Sheep Vaccine by Type
2.1 Cattle and Sheep Vaccine Market Segment by Type
2.1.1 Live Attenuated Vaccines
2.1.2 Inactivated Vaccines
2.1.3 Other
2.2 Global Cattle and Sheep Vaccine Market Size by Type
2.2.1 Global Cattle and Sheep Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Cattle and Sheep Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Cattle and Sheep Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Cattle and Sheep Vaccine Market Size by Type
2.3.1 United States Cattle and Sheep Vaccine Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Cattle and Sheep Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Cattle and Sheep Vaccine Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Cattle and Sheep Vaccine by Application
3.1 Cattle and Sheep Vaccine Market Segment by Application
3.1.1 Cattle
3.1.2 Sheep
3.2 Global Cattle and Sheep Vaccine Market Size by Application
3.2.1 Global Cattle and Sheep Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Cattle and Sheep Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Cattle and Sheep Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Cattle and Sheep Vaccine Market Size by Application
3.3.1 United States Cattle and Sheep Vaccine Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Cattle and Sheep Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Cattle and Sheep Vaccine Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Cattle and Sheep Vaccine Competitor Landscape by Company
4.1 Global Cattle and Sheep Vaccine Market Size by Company
4.1.1 Global Key Manufacturers of Cattle and Sheep Vaccine, Ranked by Revenue (2024)
4.1.2 Global Cattle and Sheep Vaccine Revenue by Manufacturer (2018-2023)
4.1.3 Global Cattle and Sheep Vaccine Sales by Manufacturer (2018-2023)
4.1.4 Global Cattle and Sheep Vaccine Price by Manufacturer (2018-2023)
4.2 Global Cattle and Sheep Vaccine Concentration Ratio (CR)
4.2.1 Cattle and Sheep Vaccine Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Cattle and Sheep Vaccine in 2024
4.2.3 Global Cattle and Sheep Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Cattle and Sheep Vaccine, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Cattle and Sheep Vaccine, Product Offered and Application
4.5 Global Key Manufacturers of Cattle and Sheep Vaccine, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Cattle and Sheep Vaccine Market Size by Company
4.7.1 Key Players of Cattle and Sheep Vaccine in United States, Ranked by Revenue (2024)
4.7.2 United States Cattle and Sheep Vaccine Revenue by Players (2018-2023)
4.7.3 United States Cattle and Sheep Vaccine Sales by Players (2018-2023)
5 Global Cattle and Sheep Vaccine Market Size by Region
5.1 Global Cattle and Sheep Vaccine Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Cattle and Sheep Vaccine Market Size in Volume by Region (2018-2034)
5.2.1 Global Cattle and Sheep Vaccine Sales in Volume by Region: 2018-2023
5.2.2 Global Cattle and Sheep Vaccine Sales in Volume Forecast by Region (2024-2034)
5.3 Global Cattle and Sheep Vaccine Market Size in Value by Region (2018-2034)
5.3.1 Global Cattle and Sheep Vaccine Sales in Value by Region: 2018-2023
5.3.2 Global Cattle and Sheep Vaccine Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Cattle and Sheep Vaccine Market Size YoY Growth 2018-2034
6.2 Americas Cattle and Sheep Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Cattle and Sheep Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Cattle and Sheep Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Cattle and Sheep Vaccine Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Cattle and Sheep Vaccine Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Cattle and Sheep Vaccine Market Size YoY Growth 2018-2034
7.2 EMEA Cattle and Sheep Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Cattle and Sheep Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Cattle and Sheep Vaccine Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Cattle and Sheep Vaccine Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Cattle and Sheep Vaccine Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Cattle and Sheep Vaccine Market Size YoY Growth 2018-2034
8.2 China Cattle and Sheep Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Cattle and Sheep Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Cattle and Sheep Vaccine Market Size YoY Growth 2018-2034
9.2 APAC Cattle and Sheep Vaccine Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Cattle and Sheep Vaccine Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Cattle and Sheep Vaccine Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Cattle and Sheep Vaccine Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Cattle and Sheep Vaccine Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Description and Business Overview
10.1.3 Merck Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Cattle and Sheep Vaccine Products Offered
10.1.5 Merck Recent Development
10.2 Zoetis
10.2.1 Zoetis Company Information
10.2.2 Zoetis Description and Business Overview
10.2.3 Zoetis Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Zoetis Cattle and Sheep Vaccine Products Offered
10.2.5 Zoetis Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Description and Business Overview
10.3.3 Boehringer Ingelheim Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Cattle and Sheep Vaccine Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Ceva
10.4.1 Ceva Company Information
10.4.2 Ceva Description and Business Overview
10.4.3 Ceva Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ceva Cattle and Sheep Vaccine Products Offered
10.4.5 Ceva Recent Development
10.5 CAHIC
10.5.1 CAHIC Company Information
10.5.2 CAHIC Description and Business Overview
10.5.3 CAHIC Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CAHIC Cattle and Sheep Vaccine Products Offered
10.5.5 CAHIC Recent Development
10.6 HVRI
10.6.1 HVRI Company Information
10.6.2 HVRI Description and Business Overview
10.6.3 HVRI Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HVRI Cattle and Sheep Vaccine Products Offered
10.6.5 HVRI Recent Development
10.7 Ringpu Biology
10.7.1 Ringpu Biology Company Information
10.7.2 Ringpu Biology Description and Business Overview
10.7.3 Ringpu Biology Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ringpu Biology Cattle and Sheep Vaccine Products Offered
10.7.5 Ringpu Biology Recent Development
10.8 Yebio
10.8.1 Yebio Company Information
10.8.2 Yebio Description and Business Overview
10.8.3 Yebio Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Yebio Cattle and Sheep Vaccine Products Offered
10.8.5 Yebio Recent Development
10.9 DHN
10.9.1 DHN Company Information
10.9.2 DHN Description and Business Overview
10.9.3 DHN Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 DHN Cattle and Sheep Vaccine Products Offered
10.9.5 DHN Recent Development
10.10 WINSUN
10.10.1 WINSUN Company Information
10.10.2 WINSUN Description and Business Overview
10.10.3 WINSUN Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 WINSUN Cattle and Sheep Vaccine Products Offered
10.10.5 WINSUN Recent Development
10.11 Elanco
10.11.1 Elanco Company Information
10.11.2 Elanco Description and Business Overview
10.11.3 Elanco Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Elanco Cattle and Sheep Vaccine Products Offered
10.11.5 Elanco Recent Development
10.12 Virbac
10.12.1 Virbac Company Information
10.12.2 Virbac Description and Business Overview
10.12.3 Virbac Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Virbac Cattle and Sheep Vaccine Products Offered
10.12.5 Virbac Recent Development
10.13 Jinyu Bio-Technology
10.13.1 Jinyu Bio-Technology Company Information
10.13.2 Jinyu Bio-Technology Description and Business Overview
10.13.3 Jinyu Bio-Technology Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Jinyu Bio-Technology Cattle and Sheep Vaccine Products Offered
10.13.5 Jinyu Bio-Technology Recent Development
10.14 ChengDu Tecbond
10.14.1 ChengDu Tecbond Company Information
10.14.2 ChengDu Tecbond Description and Business Overview
10.14.3 ChengDu Tecbond Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.14.4 ChengDu Tecbond Cattle and Sheep Vaccine Products Offered
10.14.5 ChengDu Tecbond Recent Development
10.15 CAVAC
10.15.1 CAVAC Company Information
10.15.2 CAVAC Description and Business Overview
10.15.3 CAVAC Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.15.4 CAVAC Cattle and Sheep Vaccine Products Offered
10.15.5 CAVAC Recent Development
10.16 Kyoto Biken Laboratories
10.16.1 Kyoto Biken Laboratories Company Information
10.16.2 Kyoto Biken Laboratories Description and Business Overview
10.16.3 Kyoto Biken Laboratories Cattle and Sheep Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Kyoto Biken Laboratories Cattle and Sheep Vaccine Products Offered
10.16.5 Kyoto Biken Laboratories Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Cattle and Sheep Vaccine Industry Chain Analysis
11.2 Cattle and Sheep Vaccine Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Cattle and Sheep Vaccine Production Mode & Process
11.4 Cattle and Sheep Vaccine Sales and Marketing
11.4.1 Cattle and Sheep Vaccine Sales Channels
11.4.2 Cattle and Sheep Vaccine Distributors
11.5 Cattle and Sheep Vaccine Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Cattle and Sheep Vaccine CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Cattle and Sheep Vaccine Market Trends
Table 3. Cattle and Sheep Vaccine Market Drivers
Table 4. Cattle and Sheep Vaccine Market Challenges
Table 5. Cattle and Sheep Vaccine Market Restraints
Table 6. Global Cattle and Sheep Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Cattle and Sheep Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Cattle and Sheep Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Cattle and Sheep Vaccine Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Cattle and Sheep Vaccine, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Cattle and Sheep Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Cattle and Sheep Vaccine Revenue Share by Manufacturer, 2018-2023
Table 13. Global Cattle and Sheep Vaccine Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Cattle and Sheep Vaccine Sales Share by Manufacturer, 2018-2023
Table 15. Global Cattle and Sheep Vaccine Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Cattle and Sheep Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Cattle and Sheep Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cattle and Sheep Vaccine as of 2024)
Table 18. Global Key Manufacturers of Cattle and Sheep Vaccine, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Cattle and Sheep Vaccine, Product Offered and Application
Table 20. Global Key Manufacturers of Cattle and Sheep Vaccine, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Cattle and Sheep Vaccine in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Cattle and Sheep Vaccine Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Cattle and Sheep Vaccine Revenue Share by Players, (2018-2023)
Table 25. United States Cattle and Sheep Vaccine Sales by Players, (K Units), (2018-2023)
Table 26. United States Cattle and Sheep Vaccine Sales Share by Players, (2018-2023)
Table 27. Global Cattle and Sheep Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Cattle and Sheep Vaccine Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Cattle and Sheep Vaccine Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Cattle and Sheep Vaccine Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Cattle and Sheep Vaccine Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Cattle and Sheep Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Cattle and Sheep Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Cattle and Sheep Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Cattle and Sheep Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Cattle and Sheep Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Cattle and Sheep Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Cattle and Sheep Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Cattle and Sheep Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Cattle and Sheep Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Cattle and Sheep Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Cattle and Sheep Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Cattle and Sheep Vaccine Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Cattle and Sheep Vaccine Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Cattle and Sheep Vaccine Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Cattle and Sheep Vaccine Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Merck Company Information
Table 48. Merck Description and Business Overview
Table 49. Merck Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Merck Cattle and Sheep Vaccine Product
Table 51. Merck Recent Development
Table 52. Zoetis Company Information
Table 53. Zoetis Description and Business Overview
Table 54. Zoetis Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Zoetis Cattle and Sheep Vaccine Product
Table 56. Zoetis Recent Development
Table 57. Boehringer Ingelheim Company Information
Table 58. Boehringer Ingelheim Description and Business Overview
Table 59. Boehringer Ingelheim Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Boehringer Ingelheim Cattle and Sheep Vaccine Product
Table 61. Boehringer Ingelheim Recent Development
Table 62. Ceva Company Information
Table 63. Ceva Description and Business Overview
Table 64. Ceva Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Ceva Cattle and Sheep Vaccine Product
Table 66. Ceva Recent Development
Table 67. CAHIC Company Information
Table 68. CAHIC Description and Business Overview
Table 69. CAHIC Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. CAHIC Cattle and Sheep Vaccine Product
Table 71. CAHIC Recent Development
Table 72. HVRI Company Information
Table 73. HVRI Description and Business Overview
Table 74. HVRI Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. HVRI Cattle and Sheep Vaccine Product
Table 76. HVRI Recent Development
Table 77. Ringpu Biology Company Information
Table 78. Ringpu Biology Description and Business Overview
Table 79. Ringpu Biology Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Ringpu Biology Cattle and Sheep Vaccine Product
Table 81. Ringpu Biology Recent Development
Table 82. Yebio Company Information
Table 83. Yebio Description and Business Overview
Table 84. Yebio Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Yebio Cattle and Sheep Vaccine Product
Table 86. Yebio Recent Development
Table 87. DHN Company Information
Table 88. DHN Description and Business Overview
Table 89. DHN Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. DHN Cattle and Sheep Vaccine Product
Table 91. DHN Recent Development
Table 92. WINSUN Company Information
Table 93. WINSUN Description and Business Overview
Table 94. WINSUN Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. WINSUN Cattle and Sheep Vaccine Product
Table 96. WINSUN Recent Development
Table 97. Elanco Company Information
Table 98. Elanco Description and Business Overview
Table 99. Elanco Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Elanco Cattle and Sheep Vaccine Product
Table 101. Elanco Recent Development
Table 102. Virbac Company Information
Table 103. Virbac Description and Business Overview
Table 104. Virbac Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Virbac Cattle and Sheep Vaccine Product
Table 106. Virbac Recent Development
Table 107. Jinyu Bio-Technology Company Information
Table 108. Jinyu Bio-Technology Description and Business Overview
Table 109. Jinyu Bio-Technology Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Jinyu Bio-Technology Cattle and Sheep Vaccine Product
Table 111. Jinyu Bio-Technology Recent Development
Table 112. ChengDu Tecbond Company Information
Table 113. ChengDu Tecbond Description and Business Overview
Table 114. ChengDu Tecbond Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. ChengDu Tecbond Cattle and Sheep Vaccine Product
Table 116. ChengDu Tecbond Recent Development
Table 117. CAVAC Company Information
Table 118. CAVAC Description and Business Overview
Table 119. CAVAC Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. CAVAC Cattle and Sheep Vaccine Product
Table 121. CAVAC Recent Development
Table 122. Kyoto Biken Laboratories Company Information
Table 123. Kyoto Biken Laboratories Description and Business Overview
Table 124. Kyoto Biken Laboratories Cattle and Sheep Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Kyoto Biken Laboratories Cattle and Sheep Vaccine Product
Table 126. Kyoto Biken Laboratories Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Cattle and Sheep Vaccine Customers List
Table 130. Cattle and Sheep Vaccine Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Cattle and Sheep Vaccine Product Picture
Figure 2. Global Cattle and Sheep Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Cattle and Sheep Vaccine Market Size 2018-2034 (US$ Million)
Figure 4. Global Cattle and Sheep Vaccine Sales 2018-2034 (K Units)
Figure 5. United States Cattle and Sheep Vaccine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Cattle and Sheep Vaccine Market Size 2018-2034 (US$ Million)
Figure 7. United States Cattle and Sheep Vaccine Sales 2018-2034 (K Units)
Figure 8. United States Cattle and Sheep Vaccine Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Cattle and Sheep Vaccine Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Cattle and Sheep Vaccine Report Years Considered
Figure 11. Product Picture of Live Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Other
Figure 14. Global Cattle and Sheep Vaccine Market Share by Type in 2024 & 2034
Figure 15. Global Cattle and Sheep Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 16. Global Cattle and Sheep Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 17. Global Cattle and Sheep Vaccine Sales by Type (2018-2034) & (K Units)
Figure 18. Global Cattle and Sheep Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 19. Global Cattle and Sheep Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 20. United States Cattle and Sheep Vaccine Market Share by Type in 2024 & 2034
Figure 21. United States Cattle and Sheep Vaccine Sales in Value by Type (2018-2034) & (US$ Million)
Figure 22. United States Cattle and Sheep Vaccine Sales Market Share in Value by Type (2018-2034)
Figure 23. United States Cattle and Sheep Vaccine Sales by Type (2018-2034) & (K Units)
Figure 24. United States Cattle and Sheep Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 25. United States Cattle and Sheep Vaccine Price by Type (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Cattle
Figure 27. Product Picture of Sheep
Figure 28. Global Cattle and Sheep Vaccine Market Share by Application in 2024 & 2034
Figure 29. Global Cattle and Sheep Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Cattle and Sheep Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Cattle and Sheep Vaccine Sales by Application (2018-2034) & (K Units)
Figure 32. Global Cattle and Sheep Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Cattle and Sheep Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 34. United States Cattle and Sheep Vaccine Market Share by Application in 2024 & 2034
Figure 35. United States Cattle and Sheep Vaccine Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. United States Cattle and Sheep Vaccine Sales Market Share in Value by Application (2018-2034)
Figure 37. United States Cattle and Sheep Vaccine Sales by Application (2018-2034) & (K Units)
Figure 38. United States Cattle and Sheep Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 39. United States Cattle and Sheep Vaccine Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Cattle and Sheep Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Cattle and Sheep Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Cattle and Sheep Vaccine Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Cattle and Sheep Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Cattle and Sheep Vaccine Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Cattle and Sheep Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Cattle and Sheep Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Cattle and Sheep Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Cattle and Sheep Vaccine Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Cattle and Sheep Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Cattle and Sheep Vaccine Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Cattle and Sheep Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Cattle and Sheep Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Cattle and Sheep Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Cattle and Sheep Vaccine Sales by Type (2018-2034) & (K Units)
Figure 62. China Cattle and Sheep Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Cattle and Sheep Vaccine Sales by Application (2018-2034) & (K Units)
Figure 64. China Cattle and Sheep Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Cattle and Sheep Vaccine Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Cattle and Sheep Vaccine Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Cattle and Sheep Vaccine Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Cattle and Sheep Vaccine Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Cattle and Sheep Vaccine Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Cattle and Sheep Vaccine Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Cattle and Sheep Vaccine Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Cattle and Sheep Vaccine Value Chain
Figure 77. Cattle and Sheep Vaccine Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed